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A 2-kb c-mpl promoter fragment is sufficient to direct expression
to the megakaryocytic lineage and sites of embryonic
hematopoiesis in transgenic mice
Abstract
Thrombopoietin receptor c-mpl is expressed on hematopoietic progenitors and cells of the
megakaryocytic lineage. The c-mpl promoter may, therefore, be useful for directing the expression of
transgenes. We tested whether a 2-kb genomic DNA fragment comprising the putative c-mpl regulatory
elements and most of the 5'-untranslated region of mouse c-mpl is able to direct the expression of a
reporter gene to hematopoietic cells in transgenic mice. As a reporter gene we used the human placental
alkaline phosphatase (PLAP). In adult transgenic mice, PLAP expression was specifically detected in
megakaryocytes and platelets. Embryos showed PLAP reporter gene expression already in the yolk sac
at embryonic day 6.5 (E6.5) and in blood islands at E7.5. At E9.5, expression was found in blood
vessels of the yolk sac and the embryo proper, followed by high levels of expression in the fetal liver at
E11.5. Expression in E6.5 yolk sac is compatible with a function of c-mpl and its ligand,
thrombopoietin, in the earliest stages of embryonic hematopoiesis.
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Brief report
A 2-kb c-mpl promoter fragment is sufficient to direct expression to the
megakaryocytic lineage and sites of embryonic hematopoiesis in transgenic mice
Sandra Ziegler, Kurt Bu¨rki, and Radek C. Skoda
Thrombopoietin receptor c-mpl is ex-
pressed on hematopoietic progenitors
and cells of the megakaryocytic lineage.
The c-mpl promoter may, therefore, be
useful for directing the expression of
transgenes. We tested whether a 2-kb
genomic DNA fragment comprising the
putative c-mpl regulatory elements and
most of the 5-untranslated region of
mouse c-mpl is able to direct the expres-
sion of a reporter gene to hematopoietic
cells in transgenic mice. As a reporter
gene we used the human placental alka-
line phosphatase (PLAP). In adult trans-
genic mice, PLAP expression was specifi-
cally detected in megakaryocytes and
platelets. Embryos showed PLAP re-
porter gene expression already in the
yolk sac at embryonic day 6.5 (E6.5) and
in blood islands at E7.5. At E9.5, expres-
sion was found in blood vessels of the
yolk sac and the embryo proper, followed
by high levels of expression in the fetal
liver at E11.5. Expression in E6.5 yolk sac
is compatible with a function of c-mpl and
its ligand, thrombopoietin, in the earliest
stages of embryonic hematopoiesis.
(Blood. 2002;100:1072-1074)
© 2002 by The American Society of Hematology
Introduction
Thrombopoietin (TPO) is the primary regulator of megakaryopoi-
esis and platelet production.1-4 In addition, TPO promotes the
expansion of pluripotent stem cells and early hematopoietic
progenitors without preference for a particular lineage.5 The effects
of TPO are mediated by its cell surface receptor, c-mpl, which was
initially described as the cellular homologue of the retroviral
oncogene, myeloproliferative leukemia (v-mpl)6; c-mpl is a mem-
ber of the cytokine receptor superfamily7,8 and its expression is
restricted to cells of the megakaryocytic lineage and to CD34
hematopoietic progenitors and stem cells.5
We tested whether a 2-kb genomic DNA fragment containing
the promoter and regulatory sequences of the mouse c-mpl gene
might be useful to direct expression to the megakaryocytic lineage
in transgenic mice. A 2-kb genomic DNA fragment containing
promoter and regulatory sequences of the mouse c-mpl gene was
derived. As a reporter gene, we chose the human placental alkaline
phosphatase (PLAP), a glycosylphosphatidylinositol (GPI)-linked
cell surface protein. PLAP allows sensitive and specific detection
of protein expression because of its heat-stable alkaline phospha-
tase (AP) activity.9 We found that the 2-kb c-mpl promoter
fragment was sufficient to specifically direct expression of the
PLAP reporter gene to the megakaryocytic lineage in the adult and
to the sites of early hematopoiesis in the embryo.
Study design
DNA constructs
A 2-kb HindIII –ApaI genomic fragment containing the 5 portion of the
mouse c-mpl promoter was subcloned into pBluescript KSII (Stratagene)
cut with HindIII and ApaI. The unique ApaI site was blunted using T4
polymerase and was ligated to a 120–base pair (bp) fragment generated by
polymerase chain reaction using the primers 5-GGCCCCAGAGGGGCA-
GAG-3 and 5-TGTGTGCCTGCCTTAGCC-3 (Figure 1A). This frag-
ment corresponds to the region between positions132 and13 relative to
the c-mpl translational start site and contains the 3 portion of the c-mpl
promoter and part of the 5-untranslated region (Figure 1A). SV40
polyadenylation signal and the PLAP cDNA were added to yield the
c-mpl–PLAP–SV40 transgene construct (Figure 1B). This construct was
excised as a 5-kb XhoI–NotI fragment and was used to generate transgenic
mice in the B6D2F1 background by standard oocyte pronucleus injection.
Blood and bone marrow
Blood was obtained by cardiac puncture, and blood counts were taken with
an automated blood counter (Technicon H-1; Miles, Tarrytown, NY).
Femur bones were flushed with Iscoves modified Dulbecco medium
supplemented with 10% fetal bovine serum (Gibco), and bone marrow cells
were concentrated on a glass slide by cytospin centrifugation.
Staining for alkaline phosphatase
Blood or bone marrow cells were heated to 65°C for 5 minutes, fixed in 4%
paraformaldehyde, washed in HEPES buffered saline (HBS) (150 mM
NaCl, 20 mM HEPES), and incubated for 5 to 10 minutes at room
temperature in AP staining solution containing 0.17 mg/mL BCIP and 0.33
mg/mL NBT, 100 mM Tris, pH 9.5, 100 mM NaCl, and 5 mM MgCl2.
Alkaline phosphatase activity results in blue staining.10
RNA isolation and ribonuclease protection assay
RNA from mouse tissues was isolated by the acid phenol method.11 To
assess the expression of PLAP mRNA, a ribonuclease protection assay was
performed.12 Total RNA (30 g) was simultaneously hybridized with the
following 3 riboprobes: (1) a riboprobe specific for PLAP (generated with
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Figure 1. Transgene construct and expression of
PLAP mRNA and protein in adult mice. (A) Mouse
c-mpl gene (top) with sequences of the 5-upstream
region (enlarged) aligned with the c-mpl/PLAP trans-
gene. Black box represents c-mpl exon 1. Start codons
for c-mpl and PLAP are highlighted. The transgene
retains most of the c-mpl 5-untranslated region.
(B) Transgenic construct and position of the riboprobe
used for the detection of PLAP mRNA expression. Tis-
sues of mice heterozygous for the PLAP transgene were
analyzed: bm, bone marrow; ln, mesenteric lymph node;
pa, pancreas; br, brain; lu, lung; li, liver; sp, spleen; ki,
kidney; ht, heart; th, thymus. Riboprobes for PLAP, c-mpl,
and HPRT were mixed to allow the simultaneous detec-
tion of PLAP, endogenous c-mpl, and HPRT mRNAs.
(C) PLAP protein expression in platelets and megakaryo-
cytes of wild-type (wt) and transgenic (TG) mice. Dark
staining indicates PLAP activity. Note that platelets have
aggregated in the blood smear from TG. Magnification
 500.
Figure 2. Transgene expression in mouse embryos. (A) Wild-type (wt) and transgenic (TG) embryos from E6.5 through E11.5 were collected and assayed in situ for PLAP
enzymatic activity (blue staining). Embryos from E9.5 to E11.5 are shown with yolk sac (left column) and without yolk sac (right column). a indicates allantois; br, brain; e,
embryo proper; ey, eye; fl, fetal liver; h, heart; lb, limb bud; n, notochord; p, placenta; t, tail; ys, yolk sac. Filled arrowheads point to blood islands or blood vessels in the yolk sac.
Magnification  10-20. (B) Paraffin sections at E7.5 and E9.5 show transgene expression in blood islands or blood vessels of the yolk sac. Annotations are as in panel A.
Magnification 200.
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the polymerase chain reaction primers 5-TGTTCGACGACGCCATT-
GAG-3 (sense) and 5-CTTCGTCCAGGGGCACTGCT-3 (antisense)
that resulted in the protection of a 290-nucleotide (nt) fragment; (2) a
riboprobe for mouse c-mpl (nucleotides 6 to 233 of the mouse c-mpl
cDNA sequence7) that protects a 239-nt fragment was added; and (3) a
riboprobe for mouse hypoxanthine-guanine phosphoribosyl transferase
(HPRT) to normalize for RNA loading that protected a 162-nt fragment.13
Analysis of transgene expression during embryogenesis
Timed pregnancies were obtained by natural mating in a 6 am to 7 pm light
cycle. Plugs were checked in the morning, and 12 am was taken as the time
of fertilization. Pregnant females were killed at embryonic days 6.5, 7.5,
8.5, 9.5, 10.5, and 11.5. Embryos with their yolk sacs were isolated in
phosphate-buffered saline and immediately fixed for 4 hours in 4%
paraformaldehyde. Endogenous AP activity was inactivated by heating the
embryos to 65°C for 1 hour. PLAP activity in whole mounts was detected
by AP staining for 4 hours.
Results and discussion
PLAP cDNA, as a reporter gene, was placed under the control of a
2-kb fragment containing the promoter and the regulatory se-
quences of the mouse c-mpl gene (Figure 1). Because the transcrip-
tional start site of mouse c-mpl has not been precisely mapped, we
included most of the c-mpl 5-untranslated region (Figure 1A).
Transgenic mice were generated and analyzed for expression of the
PLAP reporter gene. Of 2 transgenic lines obtained, one showed
expression and was chosen for further analysis. Using an RNase
protection assay, we detected the expression of PLAP mRNA in
bone marrow and spleen at levels comparable with endogenous
c-mpl (Figure 1B). Furthermore, PLAP protein was detectable in
megakaryocytes and platelets from transgenic mice but not in
wild-type controls (Figure 1C). Mice expressing the reporter gene
had normal peripheral blood counts (not shown); thus, expression
of the PLAP protein had no unexpected adverse effects.
The alkaline phosphatase activity of PLAP allowed us to follow
expression of the PLAP reporter gene during embryonic develop-
ment. Already at 6.5 days after coitus (E6.5), PLAP was expressed
as a ring in the yolk sac (Figure 2A). At E7.5 this staining was even
more pronounced, and sections through the yolk sac revealed
PLAP-positive cells within blood islands (Figure 2B). From E8.5
to E9.5, a major expansion of PLAP-positive cells was detectable
in the extra-embryonic blood vessels, along with the appearance of
staining within the embryo proper. Cross-sections through blood
vessels of day E9.5 yolk sac showed staining of cells associated
with the endothelium and with blood cells in the lumen (Figure
2B). Furthermore, PLAP-positive cells were also detectable in
blood vessels of the embryo, including the aorta. At E10.5, staining
of the extra-embryonic blood vessels markedly decreased, PLAP
activity was found in a punctate pattern throughout the embryo, and
strong expression of PLAP was detected in the fetal liver of
E11.5 embryos.
In summary, embryonic expression of the PLAP reporter driven
by the 2-kb c-mpl promoter followed the known sites of embryonic
hematopoiesis, starting in blood islands and later appearing in the
fetal liver. TPO/c-mpl signaling was implicated as playing a role in
early yolk sac hematopoiesis,14,15 and a recent abstract also
suggests a function in the hemangioblast.16 Our finding of PLAP
expression as early as day 6.5 further strengthens this possibility. At
later stages, expression was found in blood cells and in endothelial
cells. In accordance, the expression of c-mpl was previously
reported in a mouse liver–derived endothelial cell line, LEC-1,17
and in human umbilical cord vein–derived endothelial cells.18
Additional transgenic lines will be necessary to confirm these
results and to rule out the effects of integration site on the pattern
and the levels of expression. We expect that this c-mpl promoter
will be useful for directing the expression of other transgenes to
sites of hematopoiesis in embryos and to the megakaryocytic
lineage in adult mice.
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